|
Oct 13
|
Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now
|
|
Oct 7
|
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
|
|
Sep 6
|
Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
|
|
Sep 5
|
Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?
|
|
Aug 26
|
Denali Therapeutics (NASDAQ:DNLI) shareholders are up 3.4% this past week, but still in the red over the last three years
|
|
Jul 23
|
Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
|
|
Jun 24
|
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
|
|
May 11
|
The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
|
|
May 9
|
Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
|
|
May 8
|
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
|
|
May 7
|
Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
|
|
May 7
|
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
|
|
May 1
|
Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
|
|
Apr 29
|
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
|
|
Apr 9
|
Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
|
|
Mar 29
|
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
|
|
Mar 28
|
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
|
|
Mar 19
|
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%
|
|
Feb 1
|
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
|
|
Jan 26
|
Denali's (DNLI) Pipeline Progresses Despite Stiff Competition
|